array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Sat, 23 Nov 2024 20:53:47 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6InNYblZHWTNYWUMxWEs2V2h1NnpYc1E9PSIsInZhbHVlIjoiNFFhUHBwM1RDTENZVHVYOHZkMHJaRzNoNk5lSkhWOUg5OEREcE84b0lIU2l6TWptZjIvdFZzSEpjQ2JlYkRqc3EyVVJvQmw3SHlnMEp1WlVlYlc0SEVpWTRub0dxNWw1dUZRVzgrZFhKOEhiNnpPMWNBejJDcGpoZDZ0dEhVMjEiLCJtYWMiOiJhY2UwNWI5ZGQxYjIzYWI4NDc5NDQ3MmYxNzhlOTgxOTEwM2ViY2VjN2RmN2Y5MjQxMzE0N2ExMmUwOGM1MTIyIiwidGFnIjoiIn0%3D; expires=Sun, 23 Nov 2025 20:53:47 GMT; Max-Age=31536000; path=/; secure; samesite=lax"
    1 => "republica_session=eyJpdiI6ImNXWE9RaWhLQnpHeGtjR1Y4anFUdmc9PSIsInZhbHVlIjoiS2NDMUFaUis4amZOZmRYMGlCdjRvK0grcTVqb1RveTdtL2hPTEFuYjJVNWQ5eUpMb1BrWDRrcTh1ZUU2VWxxWDM1ZUs4T1R4b2FROUl4RUdvZXRkUnR5YUVkSk9TS3pTWWM3ZzFaRW1PWlVaU2QxZHJLMnQ5U0ZhRE1RR2tPcmsiLCJtYWMiOiJkYjRiYjI1Y2RiZjAwMDA1YjBlZmY0NWYwN2NkOGJiMmQ2YWU3YjlkMTZkNjJkMzFiNjNiZDdlM2UxNjQ3NzdiIiwidGFnIjoiIn0%3D; expires=Sun, 23 Nov 2025 20:53:47 GMT; Max-Age=31536000; path=/; secure; httponly; samesite=lax"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6InNYblZHWTNYWUMxWEs2V2h1NnpYc1E9PSIsInZhbHVlIjoiNFFhUHBwM1RDTENZVHVYOHZkMHJaRzNoNk5lSkhWOUg5OEREcE84b0lIU2l6TWptZjIvdFZzSEpjQ2JlYkRqc3EyVVJvQmw3SHlnMEp1WlVlYlc0SEVpWTRub0dxNWw1dUZRVzgrZFhKOEhiNnpPMWNBejJDcGpoZDZ0dEhVMjEiLCJtYWMiOiJhY2UwNWI5ZGQxYjIzYWI4NDc5NDQ3MmYxNzhlOTgxOTEwM2ViY2VjN2RmN2Y5MjQxMzE0N2ExMmUwOGM1MTIyIiwidGFnIjoiIn0%3D; expires=Sun, 23-Nov-2025 20:53:47 GMT; path=/; secure"
    1 => "republica_session=eyJpdiI6ImNXWE9RaWhLQnpHeGtjR1Y4anFUdmc9PSIsInZhbHVlIjoiS2NDMUFaUis4amZOZmRYMGlCdjRvK0grcTVqb1RveTdtL2hPTEFuYjJVNWQ5eUpMb1BrWDRrcTh1ZUU2VWxxWDM1ZUs4T1R4b2FROUl4RUdvZXRkUnR5YUVkSk9TS3pTWWM3ZzFaRW1PWlVaU2QxZHJLMnQ5U0ZhRE1RR2tPcmsiLCJtYWMiOiJkYjRiYjI1Y2RiZjAwMDA1YjBlZmY0NWYwN2NkOGJiMmQ2YWU3YjlkMTZkNjJkMzFiNjNiZDdlM2UxNjQ3NzdiIiwidGFnIjoiIn0%3D; expires=Sun, 23-Nov-2025 20:53:47 GMT; path=/; secure; httponly"
  ]
]
Oxford COVID-19 vaccine trials produce robust immune response in elderly

Oxford COVID-19 vaccine trials produce robust immune response in elderly

Create an account, or log in
